Pierre Hainaut

Professor, Cancer Biology. Director, IAB

Université Grenoble Alpes

France

Research Interests

Explore related searches

Professors in France Professors in Cancer Biology Cancer Biology professors in France

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Pierre Hainaut is a leading researcher in Cancer Biology at Université Grenoble Alpes, France. He serves as the Director of the IAB and is focused on understanding the genetic and molecular mechanisms underlying various cancers, including the study of TP53 variants and their implications in Li-Fraumeni syndrome. His recent work also highlights significant findings in breast cancer metastasis and the genetic factors influencing multiple myeloma across different ethnic groups.

Articles (10)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (4)

José J. G. Moura

Universidade de Aveiro

PORTUGAL

View details

Kara Maxwell

Assistant Professor

University of Pennsylvania

UNITED STATES

View details

Luisa Maia

Universidade Nova de Lisboa

PORTUGAL

View details

Andreas Joerger

Goethe University Frankfurt

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Pierre Hainaut

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

TP53 variant clusters stratify phenotypic diversity in germline carriers and reveal an osteosarcoma-prone subgroup

Clustering of <i>TP53</i> variants into functional classes correlates with cancer risk and identifies different phenotypes of Li-Fraumeni syndrome.

Germline p.R181H variant in TP53 in a family exemplifying the genotype-phenotype correlations in Li-Fraumeni syndrome.

Author Correction: Cytoskeleton remodeling induced by SMYD2 methyltransferase drives breast cancer metastasis.

Cytoskeleton remodeling induced by SMYD2 methyltransferase drives breast cancer metastasis.

From cultivation to cancer: formation of <i>N</i>-nitrosamines and other carcinogens in smokeless tobacco and their mutagenic implications.

Exploring the genetic and molecular basis of differences in multiple myeloma of individuals of African and European descent.

Reply to Li and Colleagues.

Reply to Evans and Woodward.

First Molecular Characterization of Chronic Hepatitis B Carriers in Timbuktu, Mali.

Collaborators (4)

José J. G. Moura

Kara Maxwell

Luisa Maia

Andreas Joerger

Make your next move.

Pierre Hainaut

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

TP53 variant clusters stratify phenotypic diversity in germline carriers and reveal an osteosarcoma-prone subgroup

Clustering of &lt;i&gt;TP53&lt;/i&gt; variants into functional classes correlates with cancer risk and identifies different phenotypes of Li-Fraumeni syndrome.

Germline p.R181H variant in TP53 in a family exemplifying the genotype-phenotype correlations in Li-Fraumeni syndrome.

Author Correction: Cytoskeleton remodeling induced by SMYD2 methyltransferase drives breast cancer metastasis.

Cytoskeleton remodeling induced by SMYD2 methyltransferase drives breast cancer metastasis.

From cultivation to cancer: formation of <i>N</i>-nitrosamines and other carcinogens in smokeless tobacco and their mutagenic implications.

Exploring the genetic and molecular basis of differences in multiple myeloma of individuals of African and European descent.

Reply to Li and Colleagues.

Reply to Evans and Woodward.

First Molecular Characterization of Chronic Hepatitis B Carriers in Timbuktu, Mali.

Collaborators (4)

José J. G. Moura

Kara Maxwell

Luisa Maia

Andreas Joerger

Make your next move.

Clustering of <i>TP53</i> variants into functional classes correlates with cancer risk and identifies different phenotypes of Li-Fraumeni syndrome.